Page last updated: 2024-09-02

ci 988 and 1,2-dihydroxybenzene-3,5-disulfonic acid disodium salt

ci 988 has been researched along with 1,2-dihydroxybenzene-3,5-disulfonic acid disodium salt in 1 studies

Compound Research Comparison

Studies (ci 988)	Trials (ci 988)	Recent Studies (post-2010) (ci 988)	Studies (1,2-dihydroxybenzene-3,5-disulfonic acid disodium salt)	Trials (1,2-dihydroxybenzene-3,5-disulfonic acid disodium salt)	Recent Studies (post-2010) (1,2-dihydroxybenzene-3,5-disulfonic acid disodium salt)
147	8	14	284	0	70

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Jensen, RT; Moody, TW; Moreno, P; Nuche-Berenguer, B	1

Other Studies

1 other study(ies) available for ci 988 and 1,2-dihydroxybenzene-3,5-disulfonic acid disodium salt

Article	Year
CI-988 Inhibits EGFR Transactivation and Proliferation Caused by Addition of CCK/Gastrin to Lung Cancer Cells. Journal of molecular neuroscience : MN, 2015, Volume: 56, Issue:3 Topics: 1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Dipeptides; ErbB Receptors; Gastrins; Gefitinib; Hormone Antagonists; Humans; Indoles; Lung Neoplasms; Meglumine; Pyrimidines; Quinazolines	2015

Article

Year

CI-988 Inhibits EGFR Transactivation and Proliferation Caused by Addition of CCK/Gastrin to Lung Cancer Cells.

Journal of molecular neuroscience : MN, 2015, Volume: 56, Issue:3

Topics: 1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Dipeptides; ErbB Receptors; Gastrins; Gefitinib; Hormone Antagonists; Humans; Indoles; Lung Neoplasms; Meglumine; Pyrimidines; Quinazolines

2015